Factor XI as a new target for prevention of thromboembolism in cardiovascular disease: a meta-analysis of randomized controlled trials Ahmed E. AliMohamed K. AwadMuhammad S. Mazroua OriginalPaper 18 May 2024 Pages: 1 - 14
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management Richard C. BeckerUdaya S. TantryPaul A. Gurbel ReviewPaper Open access 23 August 2024 Pages: 15 - 49
Clot lysis time and thrombin generation in patients undergoing transcatheter aortic valve implantation Aleksander SiniarskiAleksandra GąseckaGrzegorz Gajos OriginalPaper Open access 08 August 2024 Pages: 50 - 61
E-Cigarettes induce expression of procoagulant tissue factor in cultivated human endothelial cells Plinio CirilloMariarosaria MorelloGiovanni Cimmino OriginalPaper 29 August 2024 Pages: 62 - 70
Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital Mattia GalliSergio TerracinaFabio M. Pulcinelli OriginalPaper Open access 06 September 2024 Pages: 71 - 83
Ghrelin may protect against vascular endothelial injury in Acute traumatic coagulopathy by mediating the RhoA/ROCK/MLC2 pathway Chengjian HeXiaojing SongRongjun Xie OriginalPaper Open access 23 August 2024 Pages: 84 - 95
Correction: Ghrelin may protect against vascular endothelial injury in acute traumatic coagulopathy by mediating the RhoA/ROCK/MLC2 pathway Chengjian HeXiaojing SongRongjun Xie Correction Open access 24 November 2024 Pages: 96 - 96
Clinical outcomes of patients with atrial fibrillation in relation to multimorbidity status changes over time and the impact of ABC pathway compliance: a nationwide cohort study Rungroj KrittayaphongArjbordin WinijkulGregory Y. H. Lip OriginalPaper 09 July 2024 Pages: 97 - 108
Finding individualised treatment in obese needing enoxaparin (FIT ONE): a multicentre study of therapeutic enoxaparin and the role of anti-factor Xa monitoring Marcelle AppayJustine LaiJan-Willem Alffenaar OriginalPaper Open access 27 August 2024 Pages: 109 - 119
Prognostic outcome of intravenous thrombolysis in elderly patients aged ≥ 60 years with acute ischemic stroke by ASTRAL and THRIVE scales Yani FanGuoyan ShiLili Chen OriginalPaper 06 September 2024 Pages: 120 - 125
Risk of incident venous thromboembolism in patients with atopic dermatitis: systematic analysis of the literature and meta-analysis Yifei WangZhiqiang ChenChen Shen ReviewPaper 06 September 2024 Pages: 126 - 135
Eosinopenia in patients with acute myocardial infarction- longitudinal imaging insights from the CAPRI study Bilal BawamiaAshish GuptaMohammad Alkhalil OriginalPaper 21 September 2024 Pages: 136 - 144
A nomogram predicting venous thromboembolism risk in primary liver cancer patients Haike LeiXiaosheng LiJing Xiao OriginalPaper Open access 21 September 2024 Pages: 145 - 156
Intravenous thrombolysis or dual antiplatelet therapy for minor ischemic stroke? Li ZhouMingxin Wang Letter to the Editor 03 October 2024 Pages: 157 - 158
Letter to the editor to ‘‘Elevated plasma protein carbonylation increases the risk of ischemic cerebrovascular events in patients with atrial fibrillation: association with a prothrombotic state’’ Qinmei HuangWenjing Cheng Letter to the Editor 05 October 2024 Pages: 159 - 160
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management Luis Del Carpio-Orantes Letter to the Editor 04 November 2024 Pages: 161 - 161
Correction to: Anticoagulation control among patients on vitamin K antagonists in nine countries in SubSaharan Africa Julius Chacha MwitaJoel Msafri FrancisKaren Cohen Correction Open access 30 September 2024 Pages: 162 - 163